The provision of Essential medicine is one of the eight pillars of WHO’s primary health care strategy. According to WHO, essential medicines are those drugs that fulfill the priority health care need of people. Essential drug is defined as the appropriate medicine intended to be available in the content of functioning health system every time in adequate amount in the appropriate dosage form with assured quality and adequate information at affordable price that each and every individual can afford.
2. The provision of Essential medicine is one of the eight
pillars of WHO’s primary health care strategy. According to
WHO, essential medicines are those drugs that fulfill the
priority health care need of people. Essential drug is
defined as the appropriate medicine intended to be
available in the content of functioning health system every
time in adequate amount in the appropriate dosage form
with assured quality and adequate information at
affordable price that each and every individual can afford.
This is the basis of the Essential medicine concept that was
launched in 1977. This concept needs to flexible and
adaptable to different situations and nation should have
responsibility to determine the essential medicines and
release their own essential medicine list. The essential
medicine list should be prepared on the basis of common &
prevalent disease exists in their regions and nations .The
aim of the essential medicine is to support the rational use
of the drugs by each individual and every communities of
the world.
3. Most rational prescribing and use of drugs
Environmental condition
Pattern of prevalent disease
Level of treatment facility available in their
regions
Efficacy and safety profile of drug
Quality, price, and local availability
4. are those common diseases/infections which
are widespread in each and every group of
populations in particular zones/nations for
longer period. In India, hypertension,
diabetes, ischaemic heart diseases are the
most common diseases found across the
whole country. Occasional outbreak of
dengue fever also prevails its dominance over
the years.
5. Rational use of drugs requires that "patients
receive medications appropriate to their
clinical needs, in doses that meet their own
individual requirements, for an adequate
period of time, and at the lowest cost to them
and their community" Irrational use of
medicines is a major global problem. WHO
estimates that more than half of all medicines
are prescribed, dispensed or sold
inappropriately, and that half of all patients
fail to take them correctly.
6. The irrational use of drugs is due to:
use of too many medicines per patient ("poly-
pharmacy")
inappropriate use of antimicrobials
often in inadequate dosage, for non-bacterial
infections
over-use of injections when oral formulations
would be more appropriate
failure to prescribe in accordance with clinical
guidelines
inappropriate self-medication,
Often of prescription-only medicines; non-
adherence to dosing regimes
7. WHO advocates 12 key interventions to promote more rational use:
Establishment of a multidisciplinary national body to coordinate policies
on medicine use
Use of clinical guidelines
Development and use of national essential medicines list
Establishment of drug and therapeutics committees in districts and
hospitals
Inclusion of problem-based pharmacotherapy training in undergraduate
curricula
Continuing in-service medical education as a licensure requirement
Supervision, audit and feedback
Use of independent information on medicines
Public education about medicines
Avoidance of perverse financial incentives
Use of appropriate and enforced regulation
Sufficient government expenditure to ensure availability of
medicines and staff.
8. Of the 414 eligible medicines on WHO’s
model list, 73 (18%) medicines were listed by
only 27 (20%) or fewer countries and 23 (6%)
medicines were listed by 7 (5%) or fewer
countries. Medicines recently added to WHO’s
model list were generally listed by fewer
countries than those medicines added earlier
(available from a data repository). Only
velpatasvir, a Hepatitis C treatment, which
was added to the 2017 WHO model list , was
not listed by any country.
9. No country included all medicines on WHO’s
model list; eight countries included over 300
WHO essential medicines on their list (Ethiopia,
Iran [Islamic Republic of], Kenya, Pakistan,
Republic of Moldova, Slovakia, Syrian Arab
Republic and Thailand). Of these, Kenya, Pakistan
and the Republic of Moldova listed WHO essential
medicines without adding many (less than 150)
other medicines.
Portugal, Slovakia and Syrian Arab Republic
added more than 600 medicines to their list that
were not on WHO’s model list; while Angola,
Bosnia and Herzegovina, Bulgaria, Cambodia and
Somalia omitted more than 300 WHO essential
medicines.
10. There were differences across therapeutic
areas and for both communicable and no
communicable diseases (available from a data
repository). Countries with lower health-care
expenditures appear to have omitted more
medicine of WHO’s Essential list.
Essential medicine not only saves life and
prevents epidemics and diseases too.
11. India
Prevalent diseases and their essential medicines :
Prevalent diseases Essential medicines as per rational use
Hypertension Amlodipine, atenolol, enapril,
hydrocholorothiazide, labetalol, methyl
dopa, ramipril, telmisartan
Diabetes Glimpiride, insulin, metformin
Dengue Paracetamol, dengue vaccine
Hyperlipidemia Atorvastatin
31. Qatar
Prevalent disease Essential drugs as per rational use
Cancer Methotrexate, topotecan, etopioside,
carboplatin, cisplatin
Ischemic disease Bisoprolol, glyceryl trinitrite, isosorbide
dinitrite, verapamil
Respiratory disease Salbutamol, salmeterol, Albuterol, ipratropium
bromide
32. Saudi Arab
Prevalent disease Essential drugs as per rational use
Stroke Simbuvastatin, digoxin, diltiazem
Chronic kidney disease Furesemide, toresemide, ethacryanic
acid
Liver cirrhosis Ursodiol,actigall
33. U.A.E
Prevalent disease Essential drugs as per rational use
Cancer Methotrexate, bleomycin, avastin, cisplatin,
etopioside, topotecan
Obesity Fenterimine, topiramate, naltrexone,
methamphetamine, orlistat ,phendimethazine
34. Vatican city
Prevalent disease Essential drugs as per rational use
Parasitic Infections Mebendazole, albendazole,
ivermectin, avermectin,piperazine
Cancer Methotrexate, bleomycin, avastin,
cisplatin, etopioside, topotecan
35. Belgium
Prevalent disease Essential drugs as per rational use
Heart disease Diltiazem, nifidem, simbuvastatin, losartan,
digoxin, propranolol, amlodipine
Arthritis Azathioprine, hydroxychloroquine,
leflunomide, methotrexate, sulfasalazine
Athetosis Reserpine, terbenazine
37. Uruguay
Prevalent disease Essential drugs as per rational use
Cardiovascular disease Diltiazem, nifidem, simbuvastatin,
losartan, digoxin, propranolol,
amlodipine
38. Panama
Prevalent disease Essential drugs as per rational use
Rabies Rabies vaccine(rabD)
Typhoid Ceftriaxone, azithromycin, ciprofloxacin
yellow fever Yellow fever vaccine
39. Mexico
Prevalent disease Essential drugs as per rational use
Zika virus Symptomatic treatment with
acetaminophen
Chickenguinea Symptomatic treatment with
acetaminophen, Ibruprofen
Parasitic infections Pyrantel pamoate, mebendazole,
thiabendazole, ivermectin,
avermectin, diethyl carbamezepine,
piparizine
40. Italy
Prevalent disease Essential drugs as per rational use
Cerebrovascular diseases Propranolol, simbuvastatin, losartan,
diltiazem, amlodipin
Ischaemic heart diseases Bisoprolol, glyceryl trinitrite, dinitrite,
verapamil
41. France
Prevalent disease Essential drugs as per rational
use
Boils Cefazoline, tetracycline,
cefixime, erythromycin,
doxycycline
Breast cancer Abimaciclib, palclitaxel, afinitor,
toremifene, taxotere, vinblastin
42. North Korea
Prevalent disease Essential drugs as per
rational use
Tb Capreomycin, rifampicin,
streptomycin, ethambutol
Viral hepatitis Entecavir, pegylated interferon
alfa 2a & 2b, ribavirin,
sofosbuvir, tenofovir
Malaria Chloroquine, artesunate,
arthemether+lumefantrine,
hydroxychloroquine
50. Iran
Prevalent disease Essential drugs as per rational use
Dengue Acetaminophen, dengue vaccine
T cell leukemia Bendamustin, bortezomib, brentuximumab
Crimean congo hemorrhagic fever Ribavarin
51. Manmayar
Prevalent disease Essential drugs as per rational use
Filariasis Albendazole, mebendazole, ivermectin,
avermectin, DEC
Anthrax Ciprofloxacin, doxycycline, ofloxacin,
chloramphenicol, vibramycin,
obiltoxaximab
Avian influenza Osaltamivir, zanamivir, peramivir
52. Laos
Prevalent disease Essential drugs as per rational use
LRTI Salbutamol, salmeterol, budesonide, Albuterol,
ipratropium bromide
Ischemic heart disease Bisoprolol, glyceryl trinitrite, isosorbide dinitrite,
verapamil
Diarrhea Metronidazole, ORS Solution
53. Philippines
Prevalent disease Essential drugs as per rational use
Hepatitis A Hepatitis A vaccine
Japenese Encephelitis Japanese encephalitis vaccine(SA14-14-2
Live attenuated)
Leptospirosis Ampicillin, penillin g. potassium, penicillin
g. sodium
54. Somalia
Prevalent disease Essential drugs as per rational use
Cholera Doxycline, erythromycin ,vaxchora vaccine
Meningitis Amoxiclin ,vancomycin, ciprofloxacin,
metronidazole
Malaria Chloroquine, arthemether+lumefantrine,
artesunate
Measles Ibuprofen, acetaminophen, naproxen Na
55. Holland
Prevalent disease Essential drugs as per rational use
Neoplasm Methotrexate, cisplatin, carboplatin, topotecan,
etopioside
Respiratory diseases Aminophyllin, beclomethasone, salbutamol,
theophyllin
56. REFERENCES:
1.WHO,The Pursuit of Responsible Use of
Medicines: Sharing and Learning from Country
; October 2012;WHO reference
number: WHO/EMP/MAR/2012.
2.Comparison of essential medicines lists in 137
countries; Bulletin of World Health Organ 2019